Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

브리핑

[아주경제 코이너스 브리핑] “If you buy a Tesla car with bitcoin, you may get a tax bomb”

[아주경제 코이너스 브리핑] “If you buy a Tesla car with bitcoin, you may get a tax bomb”

[김현호의 CEO 브리핑] “Adu MK” Hyundai Motor Company’s resignation from the management line after 51 years

[김현호의 CEO 브리핑] “Adu MK” Hyundai Motor Company’s resignation from the management line after 51 years

[김창수의 e뉴스 브리핑] Yuhan Corporation to invest 10 billion won in April Bio… 2nd major shareholder registration, etc.

[김창수의 e뉴스 브리핑] Yuhan Corporation to invest 10 billion won in April Bio… 2nd major shareholder registration, etc.

[김현호의 CEO 브리핑] Kia President Song Ho-sung, “We will grow to No. 1 in EVs and PBVs”, etc.

[김현호의 CEO 브리핑] Kia President Song Ho-sung, “We will grow to No. 1 in EVs and PBVs”, etc.

[가상자산 브리핑] Ada plunged 11%… Major US bank “DeFi has higher potential than BTC”

[가상자산 브리핑] Ada plunged 11%… Major US bank “DeFi has higher potential than BTC”

[아주경제 코이너스 브리핑] The National Tax Service, secured 33.6 billion won in cryptocurrency for large delinquent payments, etc.

[아주경제 코이너스 브리핑] The National Tax Service, secured 33.6 billion won in cryptocurrency for large delinquent payments, etc.

[김창수의 e뉴스 브리핑] Chong Kun Dang’Napa Beltan’ applied for conditional permission for corona treatment, etc.

[김창수의 e뉴스 브리핑] Chong Kun Dang’Napa Beltan’ applied for conditional permission for corona treatment, etc.

[주간 IT뉴스 브리핑] Nexon, other than the promise of item’reinforcement probability disclosure’

[주간 IT뉴스 브리핑] Nexon, other than the promise of item’reinforcement probability disclosure’

[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.

[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.

[김창수의 e뉴스 브리핑] Artenex “FDA demands supplementation of marketing permission for’Oraxol’”… Misapproval

[김창수의 e뉴스 브리핑] Artenex “FDA demands supplementation of marketing permission for’Oraxol’”… Misapproval

[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency

[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency

[김창수의 e뉴스 브리핑] Korea-US NASH innovative new drug, Korea New Drug Development Award Technology Export Award, etc.

[김창수의 e뉴스 브리핑] Korea-US NASH innovative new drug, Korea New Drug Development Award Technology Export Award, etc.

Older posts
Page1 Page2 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en